Reistone Biopharma Company Limited
Clinical trials sponsored by Reistone Biopharma Company Limited, explained in plain language.
-
New pill aims to cut COPD attacks in half
Disease control Recruiting nowThis study tests whether a new tablet called RSS0343 can safely reduce the number of moderate or severe COPD flare-ups. About 300 adults with COPD will receive either the drug or a placebo for 48 weeks. The main goal is to see if the drug lowers the yearly rate of serious breathi…
Phase: PHASE2 • Sponsor: Reistone Biopharma Company Limited • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Healthy volunteers needed to test safety of new lung drug
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called RSS0343 in 48 healthy adults to see if it is safe and how the body handles it. Participants take the drug or a placebo by mouth for a short time. The goal is to check for side effects and measure drug levels in the blood. This study …
Phase: PHASE1 • Sponsor: Reistone Biopharma Company Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC